ELUTIA INC. - CLASS A

Aziyo Announces FDA 510(k) Submission for CanGaroo® RM, its Next-Generation Biomaterial Envelope Enhanced with Antibiotics

04 Apr 2022 08:00:02 By Nasdaq GlobeNewswire

Aziyo Biologics to Participate in the Lytham Partners Spring 2022 Investor Conference

31 Mar 2022 18:50:00 By Nasdaq GlobeNewswire

Aziyo Biologics Reports Fourth Quarter and Full Year 2021 Financial Results

03 Mar 2022 16:01:00 By Nasdaq GlobeNewswire

Aziyo Biologics to Participate in the Cowen 42nd Annual Health Care Conference

23 Feb 2022 16:01:00 By Nasdaq GlobeNewswire

Aziyo Biologics to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 3, 2022

17 Feb 2022 16:01:00 By Nasdaq GlobeNewswire

Aziyo Biologics to Present at the H.C. Wainwright Bioconnect Virtual Conference

27 Dec 2021 16:01:00 By Nasdaq GlobeNewswire

Aziyo Biologics Announces Closing of $14.0 Million Private Placement

08 Dec 2021 17:31:29 By Nasdaq GlobeNewswire

Aziyo Biologics Announces $14.0 Million Private Placement

06 Dec 2021 06:59:00 By Nasdaq GlobeNewswire

Aziyo Biologics to Participate in Upcoming Virtual Investor Conferences

15 Nov 2021 16:05:02 By Nasdaq GlobeNewswire

Aziyo Biologics Reports Third Quarter 2021 Financial Results

09 Nov 2021 16:01:01 By Nasdaq GlobeNewswire

Aziyo Biologics Provides Business Update and Preliminary Third Quarter 2021 Revenue Results and Announces Timing for Third Quarter 2021 Financial Results

25 Oct 2021 16:01:00 By Nasdaq GlobeNewswire

Aziyo Biologics to Participate in the 2021 Cantor Global Healthcare Conference

15 Sep 2021 16:05:00 By Nasdaq GlobeNewswire

Aziyo Biologics Appoints Peter G. Edwards as General Counsel

31 Aug 2021 16:05:00 By Nasdaq GlobeNewswire

Aziyo Biologics Reports Second Quarter 2021 Financial Results

09 Aug 2021 16:01:00 By Nasdaq GlobeNewswire

Aziyo Biologics to Report Second Quarter 2021 Financial Results on Monday, August 9, 2021

26 Jul 2021 16:01:00 By Nasdaq GlobeNewswire

Aziyo Biologics Comments on June 2nd Voluntary Recall of One Lot of its FiberCel Fiber Viable Bone Matrix

07 Jun 2021 08:00:02 By Nasdaq GlobeNewswire

Aziyo Biologics Announces Initiation of De Novo CanGaroo Clinical Study

28 Apr 2021 16:05:01 By Nasdaq GlobeNewswire

Aziyo Biologics to Participate in the Truist Securities Life Sciences Summit

26 Apr 2021 16:05:00 By Nasdaq GlobeNewswire

Aziyo Biologics to Report First Quarter 2021 Financial Results on Tuesday, May 4, 2021

20 Apr 2021 16:05:00 By Nasdaq GlobeNewswire

Aziyo Biologics Reports Fourth Quarter and Full Year 2020 Financial Results

01 Mar 2021 16:05:00 By Nasdaq GlobeNewswire